AIP
NTGN

Ameritas Investment Partners’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

Ameritas Investment Partners’s Portfolio NTGN Stock Details NTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-485
Closed -$1K – 3238
2020
Q1 		$1K Hold
485
– – ﹤0.01% 3025
2019
Q4 		$1K Hold
485
– – ﹤0.01% 3008
2019
Q3 		$1K Hold
485
– – ﹤0.01% 3057
2019
Q2 		$2K Hold
485
– – ﹤0.01% 3031
2019
Q1 		$3K Hold
485
– – ﹤0.01% 2934
2018
Q4 		$2K Hold
485
– – ﹤0.01% 2969
2018
Q3 		$4K Buy
+485
New +$5.38K ﹤0.01% 2978

Ameritas Investment Partners's NTGN Position: Q2 2020 in Review

Ameritas Investment Partners sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q2 2020, closing a stake of 485 shares — an estimated $1K sold.

Ameritas Investment Partners first reported a position in NTGN in Q3 2018 and held it in 7 quarters. The position peaked at $4K in Q3 2018. 0 funds tracked by Wall St. Rank hold NTGN as of Q2 2020.

  • Ameritas Investment Partners reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Ameritas Investment Partners sold 485 Neon Therapeutics, Inc. Common Stock shares in Q2 2020, an estimated $1K.
  • Ameritas Investment Partners first reported a position in Neon Therapeutics, Inc. Common Stock in Q3 2018 and held it in 7 quarters.
  • Ameritas Investment Partners's Neon Therapeutics, Inc. Common Stock position peaked at $4K in Q3 2018.
  • 0 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q2 2020.

Based on Ameritas Investment Partners's 13F filing for Q2 2020, filed 5 Aug 2020.